Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

The data on the effects of tofacitinib on soluble proteins in patients with rheumatoid arthritis (RA) is currently very limited. We analyzed how tofacitinib treatment and thus inhibition of the Janus kinase—signal transducer and activation of transcription pathway affects the in vivo levels of infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Valli, Atte, Kuuliala, Krista, Virtanen, Anniina, Kuuliala, Antti, Palmroth, Maaria, Peltomaa, Ritva, Vidqvist, Krista-Liisa, Leirisalo-Repo, Marjatta, Silvennoinen, Olli, Isomäki, Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Autoimmunity/Autoimmune disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750823/
https://www.ncbi.nlm.nih.gov/pubmed/36124688
http://dx.doi.org/10.1093/cei/uxac085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750823/
https://www.ncbi.nlm.nih.gov/pubmed/36124688
http://dx.doi.org/10.1093/cei/uxac085

Ejemplares similares